[go: up one dir, main page]

WO2011126264A3 - 인간 줄기세포의 활성을 증가시키는 방법 - Google Patents

인간 줄기세포의 활성을 증가시키는 방법 Download PDF

Info

Publication number
WO2011126264A3
WO2011126264A3 PCT/KR2011/002358 KR2011002358W WO2011126264A3 WO 2011126264 A3 WO2011126264 A3 WO 2011126264A3 KR 2011002358 W KR2011002358 W KR 2011002358W WO 2011126264 A3 WO2011126264 A3 WO 2011126264A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cell
mesenchymal stem
human stem
increasing activity
cell aggregate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/002358
Other languages
English (en)
French (fr)
Other versions
WO2011126264A2 (ko
Inventor
김효수
강현재
이은주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seoul National University Hospital
Original Assignee
Seoul National University Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020100053183A external-priority patent/KR20110112164A/ko
Application filed by Seoul National University Hospital filed Critical Seoul National University Hospital
Priority to US13/639,169 priority Critical patent/US20130028873A1/en
Priority to BR112012025285A priority patent/BR112012025285A2/pt
Priority to AU2011239119A priority patent/AU2011239119A1/en
Priority to CN2011800180070A priority patent/CN102822331A/zh
Priority to EP11766115A priority patent/EP2557154A2/en
Publication of WO2011126264A2 publication Critical patent/WO2011126264A2/ko
Publication of WO2011126264A3 publication Critical patent/WO2011126264A3/ko
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2525/00—Culture process characterised by gravity, e.g. microgravity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

인간 중간엽 줄기세포를 중력에 반하게 배양하여 구형세포괴를 형성하는 것을 포함하는, 고활성 인간 중간엽 줄기세포괴의 제조 방법; 상기 방법에 의해 제조된 고활성 줄기세포괴; 상기 줄기세포괴를 포함하는 세포치료제; 및 인간 중간엽 줄기세포를 배양하여 구형세포괴를 형성하는 것을 포함하며, 상기 배양시 중간엽 줄기세포 내의 E-cadherin의 양을 증가시키는 것을 특징으로 하는, 고활성 인간 중간엽 줄기세포괴의 제조 방법이 제공된다.
PCT/KR2011/002358 2010-04-05 2011-04-05 인간 줄기세포의 활성을 증가시키는 방법 Ceased WO2011126264A2 (ko)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US13/639,169 US20130028873A1 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell
BR112012025285A BR112012025285A2 (pt) 2010-04-05 2011-04-05 método para aumentar a atividade em células-tronco humanas
AU2011239119A AU2011239119A1 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell
CN2011800180070A CN102822331A (zh) 2010-04-05 2011-04-05 提高人干细胞活性的方法
EP11766115A EP2557154A2 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR20100031061 2010-04-05
KR10-2010-0031061 2010-04-05
KR1020100053183A KR20110112164A (ko) 2010-04-05 2010-06-07 인간 줄기세포의 활성을 증가시키는 방법
KR10-2010-0053183 2010-06-07

Publications (2)

Publication Number Publication Date
WO2011126264A2 WO2011126264A2 (ko) 2011-10-13
WO2011126264A3 true WO2011126264A3 (ko) 2012-03-08

Family

ID=44763387

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/002358 Ceased WO2011126264A2 (ko) 2010-04-05 2011-04-05 인간 줄기세포의 활성을 증가시키는 방법

Country Status (1)

Country Link
WO (1) WO2011126264A2 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
CN106148266A (zh) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 一种免疫细胞用培养基及该培养基的添加剂
TWI724528B (zh) * 2019-09-04 2021-04-11 三顧股份有限公司 高增生活性的３ｄ結構細胞球體、其製造方法與用途
CN113577394B (zh) * 2021-07-08 2022-09-09 中国人民解放军西藏军区总医院 一种脐带间充质干细胞制备生物凝胶-细胞聚合体体系的方法及低氧条件的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100012153A (ko) * 2008-07-28 2010-02-08 서울대학교병원 인간 줄기세포에서 고활성 줄기세포를 분리하는 방법 및상기 방법에 의해 분리된 고활성 줄기 세포

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100012153A (ko) * 2008-07-28 2010-02-08 서울대학교병원 인간 줄기세포에서 고활성 줄기세포를 분리하는 방법 및상기 방법에 의해 분리된 고활성 줄기 세포

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARTOSH, T.J. ET AL.: "Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties", PROC. NATL. ACAD. SCI. USA, vol. 107, no. 31, 19 July 2010 (2010-07-19), pages 13724 - 13729, XP055232564, DOI: doi:10.1073/pnas.1008117107 *
FRITH, J.E. ET AL.: "Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential", TISSUE ENGINEERING: PART C, vol. 16, no. 4, 9 November 2009 (2009-11-09), pages 735 - 746 *
WELTER, J.F. ET AL.: "Simplification of aggregate culture of human mesenchymal stem cells as a chondrogenic screening assay", BIOTECHNIQUES, vol. 42, no. 6, June 2007 (2007-06-01), pages 732, 734 - 737, XP008097909, DOI: doi:10.2144/000112451 *
ZHU, H. ET AL.: "A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone", NATURE PROTOCOLS, vol. 5, no. 3, 25 February 2010 (2010-02-25), pages 550 - 560, XP009172805, DOI: doi:10.1038/nprot.2009.238 *

Also Published As

Publication number Publication date
WO2011126264A2 (ko) 2011-10-13

Similar Documents

Publication Publication Date Title
HUE036910T2 (hu) Eljárás alaptápközeg elõállítására kötõszöveti õssejtekhez, alaptápközeg kötõszöveti õssejtekhez és annak tenyésztésével és differenciálásával történõ alkalmazásával elõállított sejtterápiás szer
WO2011011302A3 (en) Differentiation of human embryonic stem cells
EP2633575A4 (en) NEGATIVE ACTIVE MATERIAL, METHOD FOR PRODUCING THE NEGATIVE ACTIVE MATERIAL AND LITHIUM ION BATTERY THEREWITH
WO2009007852A3 (en) Multipotent/pluripotent cells and methods
WO2010120785A3 (en) Methods and compositions for stem cell cultures
WO2009012428A3 (en) Differentiation of human embryonic stem cells
WO2012149468A3 (en) Instruments and methods for the implantation of cell-seeded substrates
EP2633577A4 (en) NEGATIVE ACTIVE MATERIAL, METHOD OF MANUFACTURING THEREOF AND LITHIUM SUBSTITUTING BATTERY THEREWITH
WO2012074818A3 (en) Compositions and methods for 3-hydroxypropionic acid production
WO2012056110A3 (en) Cell culture material based on microbial cellulose
WO2012103261A3 (en) Compositions and methods for succinate production
MX2014014337A (es) Metodo de produccion de alta concentracion de celulas madre.
WO2007115336A3 (en) A shape-based approach for scaffoldless tissue engineering
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
IL214486A (en) A method for cryogenic freezing of cells, artificial cell structures or complex 3D tissue assemblies
MX2013007650A (es) Metodo de cultivo de celulas animales.
AU2012248333A2 (en) Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
WO2009073523A3 (en) De-differentiation of human cells
WO2012126013A3 (en) Method for making pluripotent stem cells
WO2012092542A3 (en) Responsive cell culture hydrogel
WO2011112601A3 (en) Continuous flow bioreactor for magnetically stabilized three-dimensional tissue culture
CA2927062C (en) MUSCLE CELL STAMPS AND THEIR USES
CA2866697A1 (en) Reprogramming of aged adult stem cells
WO2011126264A3 (ko) 인간 줄기세포의 활성을 증가시키는 방법
WO2011142832A3 (en) Stem cells derived under low oxygen conditions

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180018007.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11766115

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13639169

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011766115

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2011239119

Country of ref document: AU

Date of ref document: 20110405

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012025285

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012025285

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20121003